Synthesis & antimicrobial activity of 6-benzyl/p-substitutedbenzyl-1, 2,4-triazine-3,5-(2H,4H)-dithione
1:CAS:528:DyaL1cXls1SktA%3D%3D
R. Ahmad A. Hasan S. Ajaz 1987 Synthesis & antimicrobial activity of 6-benzyl/p-substitutedbenzyl-1,2,4-triazine-3,5-(2H,4H)-dithione Indian J. Chem. 26B 393 394 1:CAS:528:DyaL1cXls1SktA%3D%3D
A potential therapeutic agent for treatment of Alzheimer's disease
1:CAS:528:DC%2BD3cXhslShu7o%3D 10637369
D. L. Bai X. C. Tang X. C. He A. Huperzine 2000 a potential therapeutic agent for treatment of Alzheimer's disease Curr. Med. Chem. 7 355 374 1:CAS:528:DC%2BD3cXhslShu7o%3D 10637369
The role of cannabinoids in preventing the neurodegenerative process occurring in Alzheimer's disease
10.1358/dof.2005.030.08.915811
M. L. Ceballos M. Guzman 2005 The role of cannabinoids in preventing the neurodegenerative process occurring in Alzheimer's disease Drugs Future 30 807 814 10.1358/dof.2005.030.08.915811
P. W. Elsinghorst C. M. Tanarro M. Gutschow 2006 Novel heterobivalent tacrine derivatives as cholinesterase inhibitors with notable selectivity toward butyrylcholinesterase J. Med. Chem. 49 7540 7544 1:CAS:528:DC%2BD28XhtFykurrN 10.1021/jm060742o 17149883
Effect of rivastigmine in the treatment of behavioral disturbances associated with dementia: Review of neuropsychiatric impairment in Alzheimer's disease
G. T. Grossberg 2005 Effect of rivastigmine in the treatment of behavioral disturbances associated with dementia: review of neuropsychiatric impairment in Alzheimer's disease Curr. Med. Res. Opin. 21 1631 1639 1:CAS:528:DC%2BD2MXht1Cgs77J 10.1185/030079905X65402 16238903
Alzheimer disease in the US population: Prevalence estimates using 2000 census
10.1001/archneur.60.8.1119 12925369
L. E. Hebert P. A. Scherr J. L. Bienias 2003 Alzheimer disease in the US population: prevalence estimates using 2000 census Arch. Neurol. 60 1119 1122 10.1001/archneur.60.8.1119 12925369
N. C. Inestrosa A. Alvarez C. A. Perez R. D. Moreno M. Vicente C. Linker O. I. Casanueva C. Soto J. Garrido 1996 Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme Neuron 16 881 891 1:CAS:528:DyaK28XislCmsLk%3D 10.1016/S0896-6273(00)80108-7 8608006
A. Khalid Anjum. S. Zaheer-ul-Haq M. R. Khan Atta-ur-Rahman M. I. Choudhay 2004 Kinetics and structure-activity relationship studies on pregnane-type steroidal alkaloids that inhibit cholinesterases Bioorg. Med. Chem. 12 1995 2003 1:CAS:528:DC%2BD2cXjtVKqtb8%3D 10.1016/j.bmc.2004.03.002 15080903
G. Kryger I. Silman J. L. Sussman 1999 Structure of acetylcholinesterase complexed with E-2020: implications for the design of new anti-Alzheimer drugs Structure 7 297 307 1:CAS:528:DyaK1MXitFGitbo%3D 10.1016/S0969-2126(99)80040-9 10368299
F. M. LaFerla K. N. Green S. Oddo 2007 Intracellular amyloid-beta in Alzheimer's disease Nat. Rev. Neurosci. 8 499 509 1:CAS:528:DC%2BD2sXmslWjsr8%3D 10.1038/nrn2168 17551515
Cyclocondensation of 3-amino-2-iminonaphtho[1,2-d] thiazole with α-ketocarboxylic acid derivatives: Synthesis of 2-substituted 3-oxo-3H-naphtho [1′,2′:4,5]thiazolo[3,2-b][1,2,4]triazines as potential anti-HIV agents
K. C. Liu B. J. Shih C. H. Lee 1992 Cyclocondensation of 3-amino-2-iminonaphtho[1,2-d] thiazole with α-ketocarboxylic acid derivatives: synthesis of 2-substituted 3-oxo-3H-naphtho [1′,2′:4,5] thiazolo[3,2-b][1,2,4]triazines as potential anti-HIV agents J. Heterocycl. Chem. 29 97 101 1:CAS:528:DyaK38XksVymsrg%3D 10.1002/jhet.5570290116
Design, synthesis, and biological evaluation of 7H-thiazolo[3,2-b]-1,2,4- triazin-7-one derivatives as a novel acetylcholinesterase inhibitors
S. J. Liu L. Yang Z. Jin E. F. Huang D. D. Wan H. Q. Lin C. Hu 2009 Design, synthesis, and biological evaluation of 7H-thiazolo[3,2-b]-1,2,4- triazin-7-one derivatives as a novel acetylcholinesterase inhibitors ARKIVOC x 333 348
Copolymers of p-chlorostyrene and methyl methacrylate
1:CAS:528:DyaH2cXksV0%3D 10.1021/ja01251a006
C. S. Marvel G. L. Schertz 1943 Copolymers of p-chlorostyrene and methyl methacrylate J. Am. Chem. Soc. 65 2054 2058 1:CAS:528:DyaH2cXksV0%3D 10.1021/ja01251a006
R. J. Polinsky 1998 Clinical pharmacology of rivastigmine: a new-generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease Clin. Ther. 20 634 647 1:CAS:528:DyaK1cXmtVWmtrY%3D 10.1016/S0149- 2918(98)80127-6 9737824
Synthesis of azlactones, phenylpyruvic acid and 1,2,4-triazine derivatives under microwave irradiation
10.2174/1570178054406057
E. S. Ramadan H. A. Hamid M. Hagar 2005 Synthesis of azlactones, phenylpyruvic acid and 1,2,4-triazine derivatives under microwave irradiation Lett. Org. Chem. 2 415 418 10.2174/1570178054406057
M. L. Raves M. Harel Y. P. Pang I. Silman A. P. Kozikowski J. L. Sussman 1997 Structure of acetylcholinesterase complexed with the nootropic alkaloid, (-)-huperzine A Nat. Struct. Biol. 4 57 63 1:CAS:528:DyaK2sXis1ylsg%3D%3D 10.1038/nsb0197-57 8989325
A. E. Reyes D. R. Perez A. Alvarez J. Garrido M. K. Gentry B. P. Doctor N. C. Inestrosa 1997 A monoclonal antibody against acetylcholinesterase inhibits the formation of amyloid fibrils induced by the enzyme Biochem. Biophys. Res. Commun. 232 652 655 1:CAS:528:DyaK2sXis1SisLs%3D 10.1006/bbrc.1997.6357 9126330
J. L. Sussman M. Harel F. Frolow C. Oefner A. Goldman L. Toker I. Silman 1991 Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein Science 253 872 879 1:CAS:528:DyaK3MXlslyitrc%3D 10.1126/science.1678899 1678899
R. Thomsen M. H. Christensen 2006 MolDock: A new technique for high-accuracy molecular docking J. Med. Chem. 49 3315 3321 1:CAS:528: DC%2BD28XjvFyiu7w%3D 10.1021/jm051197e 16722650
N. Tsuno 2009 Donepezil in the treatment of patients with Alzheimer's disease Expert Rev. Neurother. 9 591 598 1:CAS:528:DC%2BD1MXlt1Cltro%3D 10.1586/ern.09.23 19402770
Analysis and comparison of the drugs utilization for senile dementia in the past 3 years in Shanghai and Huadong Hospital
L. H. Wang R. J. Tong Z. P. Qian M. Q. Zhu 2002 Analysis and comparison of the drugs utilization for senile dementia in the past 3 years in Shanghai and Huadong Hospital Pharm. Care Res. 2 287 292
Design, synthesis, and biological evaluation of 5H-thiazolo[3,2-a] pyrimidine derivatives as a new type of acetylcholinesterase inhibitors
H. Zhi L. M. Chen L. L. Zhang S. J. Liu D. D. Wan H. Q. Lin C. Hu 2008 Design, synthesis, and biological evaluation of 5H-thiazolo[3,2-a]pyrimidine derivatives as a new type of acetylcholinesterase inhibitors ARKIVOC xiii 266 277